Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000009.xml
Am J Perinatol 2004; 21(6): 365-368
DOI: 10.1055/s-2004-831885
DOI: 10.1055/s-2004-831885
Late-Onset Mycobacterium abscessus Sepsis in a Very Low Birthweight Premature Infant: Diagnostic and Therapeutic Challenges
Further Information
Publication History
Publication Date:
16 August 2004 (online)
Late-onset sepsis (after 3 days of life) is a frequent a complication found in very low birth weight (VLBW, 1000 to 1500 g) premature infants. We report the second case of late-onset sepsis caused by an uncommon pathogen, Mycobacterium abscessus.
KEYWORDS
Mycobacterium abscessus - sepsis - prematurity
REFERENCES
- 1 Speert D P, Munson D, Mitchell C et al.. Mycobacterium chelonei septicemia in a premature infant. J Pediatr. 1980; 96 681-683
- 2 Tashjian J H, Coulam C B, Washington II J A. Vaginal flora in asymptomatic women. Mayo Clin Proc. 1976; 51 557-561
- 3 Phillips M S, von Reyn C F. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis. 2001; 33 1363-1374
- 4 Kusunoki S, Ezaki T. Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. Int J Syst Bacteriol. 1992; 42 240-245
- 5 Yakrus M A, Hernandez S M, Floyd M M, Sikes D, Butler W R, Metchock B. Comparison of methods for identification of Mycobacterium abscessus and M. chelonae isolates. J Clin Microbiol. 2001; 39 4103-4110
- 6 Brown BA W R. Infections due to nontuberculous Mycobacteria. In: Mandell GL BJ, Dolin R Principles and Practice of Infectious Diseases. Vol. II. Philadelphia; Curchill Livingstone 2000: 2631-2636
- 7 Brown-Elliott B A, Wallace Jr R J. Clarithromycin resistance to Mycobacterium abscessus . J Clin Microbiol. 2001; 39 2745-2746
- 8 Brown B A, Wallace Jr R J, Onyi G O, De Rosas V, Wallace III R J. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother. 1992; 36 180-184
- 9 Woods G L, Brown-Elliot B A, Desmond E P et al.. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. Wayne, PA: National Committee for Clinical Laboratory Standards 2003: 25-37
- 10 Fernandez-Roblas R, Esteban J, Cabria F, Lopez J C, Jimenez M S, Soriano F. In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob Agents Chemother. 2000; 44 181-182
- 11 Brown-Elliott B A, Wallace Jr R J, Crist C J, Mann L, Wilson R W. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents Chemother. 2002; 46 3283-3285
- 12 Wallace Jr R J, Brown-Elliott B A, Crist C J, Mann L, Wilson R W. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother. 2002; 46 3164-3167
M. Cecilia Di PentimaM.D. M.P.H.
Christiana Hospital and A. I. duPont Hospital for Children, Thomas Jefferson University
1600 Rockland Road, Wilmington, DE